NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Optune is not 15% at 5 yrs, it's like 2 patients made it 5 yrs.

The Optune dataset does not have the best long term follow-up data. And that 90% compliance set is post hock small subset junk.

But there were 16 treatment arm patients who had were known to have a pulse 5 years after randomization at a time when most had not yet been on trial for 5 years.

BTW, Leprecon understands very well what the K/M OS% is.